We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
02 Nov 2020 - 06 Nov 2020
Virtual Venue
05 Nov 2020 - 07 Nov 2020

Image: Fitness Trackers Can Predict COVID-19 Infections, Suggests Landmark Study (Photo courtesy of Scripps Research)

Fitness Trackers Can Predict COVID-19 Infections, Suggests Landmark Study

Data from the first six weeks of a landmark study has revealed that wearable devices like Fitbit are capable of identifying cases of COVID-19 by evaluating changes in heart rate, sleep and activity levels, along with self-reported symptom data - and can identify cases with greater success than looking at symptoms alone. More...
30 Oct 2020
Illustration

Moderna to Report Early Data from Ongoing COVID-19 Vaccine Trial in November

Moderna, Inc. (Cambridge, MA, USA) has said that it is all set to report early data from the late-stage trial of its experimental COVID-19 vaccine in November that will reveal whether it is effective. More...
30 Oct 2020
M.I ONE Co., Ltd
Illustration

Regeneron's COVID-19 Antibody Cocktail Significantly Reduces Virus Levels in Ongoing Phase 2/3 Trial

Regeneron Pharmaceuticals, Inc.’s (Tarrytown, NY, USA) COVID-19 outpatient trial has prospectively demonstrated that its antibody cocktail significantly reduced virus levels and the need for further medical attention. More...
30 Oct 2020
Image: More Than 90% of COVID-19 Patients Produce Strong Antibody Response to SARS-CoV-2 That Lasts for Many Months (Photo courtesy of Mount Sinai)

More Than 90% of COVID-19 Patients Produce Strong Antibody Response to SARS-CoV-2 That Lasts for Many Months

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to new research. More...
30 Oct 2020
Image: Global COVID-19 Diagnostics Market to Reach USD 9.94 Billion by Fourth Quarter of 2020 (Photo courtesy of Allied Market Research)

Global COVID-19 Diagnostics Market to Reach USD 9.94 Billion by Fourth Quarter of 2020

The global COVID-19 diagnostics industry was pegged at USD 73.19 million in the first quarter of 2020 and is projected to reach USD 9.94 billion by the fourth quarter of 2020, driven mainly by the rise in COVID-19 patients across the world, need for rapid diagnostics, and lack of specific vaccine or medicine. However, the lack of awareness among developing countries regarding precautions and dearth of diagnostic kits & medical professionals could hinder the market growth. On the contrary, the development of advanced diagnostic kits would open new opportunities for the market players in the future. More...
30 Oct 2020
Radcal
Illustration

New Technology Enables Touchless Respiratory and Heart Rate Measurement for COVID-19 Health Screening

Researchers have developed a new technology that provides a contactless method to add respiratory rate and heart rate to temperature readings, making it particularly relevant to detecting illnesses such as the flu and COVID-19. More...
30 Oct 2020
Image: The BreathSpec device was used during field trials last year in Finland (Photo courtesy of Andrew Weekes)

Non-Invasive COVID-19 Test Identifies `Breath Signatures` to Provide Almost Instant Results

Initial findings from a new study have shown how COVID-19 can be detected via a non-invasive breath test by identifying candidate biomarkers, providing almost instant results. More...
29 Oct 2020
powered by:

Product Showcase

Copyright © 2000-2020 Globetech Media. All rights reserved.